Effects of monochromatic infrared energy in patients with diabetic peripheral neuropathy: a meta-analysis of randomized clinical trials by Caroline Robinson et al.
MEETING ABSTRACT Open Access
Effects of monochromatic infrared energy in
patients with diabetic peripheral neuropathy:
a meta-analysis of randomized clinical trials
Caroline Cabral Robinson*, Patrícia S Klahr, Cinara Stein, Graciele Sbruzzi, Rodrigo Della Méa Plentz
From 20th Brazilian Diabetes Society Congress
Porto Alegre, Brazil. 11-18 November 2015
Background
Monochromatic infrared energy (MIRE), delivered through
light-emitting diodes, has been used as a non-pharmacolo-
gical complementary strategy to improve plantar sensitivity
and pain symptoms in patients with diabetic peripheral
neuropathy (DPN), but conflicting results[1,2] have been
reported.
Objective
Summarize the effect of MIRE in plantar sensitivity and
neuropathic pain in patients with DPN trough a systematic
review of randomized clinical trials.
Materials and methods
MEDLINE, EMBASE, Cochrane Central and Google
Scholar were searched for studies published up to May
2015. Two independent reviewers assessed study eligibility
based on predefined criteria and performed data extrac-
tion. Results of plantar sensitivity were in standard mean
difference, and pain were in mean difference, with 95% of
confidence intervals. Statistical heterogeneity was assessed
by Cochran’s Q test and inconsistency I2 test. A p value ≤
0.05 was statistically significant. Meta-analysis was
performed on RevMan 5.3.
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Figure 1 Flow diagram of studies included.
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Results
From 2330 abstracts, six studies met the eligibility criteria
and were included in the systematic review (304 patients;
606 feet) (Figure 1). Participants were adult individuals
with type 1 or 2 diabetes and DPN. MIRE was applied for
at least thrice a week for 30 min/day in ankles and plantar
aspect of feet. Follow-up ranged from two to 12 weeks.
Comparison group (placebo or control) did not receive
Figure 2 Effect of MIRE on: A) Plantar sensitivity; B) Pain.
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MIRE. Overall effect of MIRE in plantar sensitivity was a
statistically significant reduction in insensitive plantar
areas to the 5.07 Semmes-Weinstein monofilament [–0.54
(–1.05 to –0.03); I2: 85%]. Heterogeneity decreased after a
sensitivity analysis including only placebo studies; effect
size remained statistically significant favoring MIRE [–0.26
(–0.50 to–0.03); I2: 23%]. Overall pain symptoms
decreased but not differed between MIRE and comparison
groups [–0.88(–3.11 to 1.36); I2: 99%]. After a sensitivity
analysis including only placebo studies, heterogeneity
decreased but a statistically significant placebo effect was
found in pain relief [0.48(0.30 to 0.66); I2: 0%] (Figure 2).
Conclusion
MIRE slightly improves plantar sensitivity in DPN with
moderate confidence; further well-designed studies were
likely to change effect size and reduce heterogeneity.
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